Structural Heart, the official journal of @crfheart, is indexed in PubMed Central! Researchers and institutions worldwide can now access and read articles. https://t.co/BmOacVFZ4i #CardioTwitter #TVT2023 @ELS_Cardiology @jgranadacrf @MariaAlu3 @gb_mackensen @BGalperMD

⌛ Final chance to save! #TCT2025 is where innovators, thought leaders, and pioneers in #interventionalcardiology come together to shape the future of cardiovascular care. 🫀💡 🎯Standard rates end September 9 at 11:59 PM EDT. Don’t miss out! https://t.co/8Vtl2b0ZGk #CardioX

🔥 Innovation meets collaboration! At an #ESCCongress joint session, CRF + ESC showcased the future of #interventionalcardiology – breakthroughs, bold ideas, and global partnership. #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @georgedangas @jgranadacrf

⏳ The clock is ticking! It’s the LAST DAY to submit your abstract for #TCT2025. The deadline is 2 PM EDT today! This is your chance to share your science with the world. 🚀 Submit now! https://t.co/u4vRgC9Fql #CardioX #CardioTwitter #CardioEd #CardioResearch

✨ That’s a wrap on #CompCourse2025! A heartfelt thank you to our attendees, faculty, program directors, and supporters who made this event a standout success. We’re already looking forward to seeing you at #CompCourse2026! 🚀 #CardioX #CardioTwitter #CardioEd #CardioResearch

🌟 Now Live: Special Issue on Women in Structural Heart Disease We’re proud to share this edition highlighting the women leading innovation, research, & collaboration. Curated by guest editor Dr. Anita Asgar, it’s a powerful look at excellence in action! https://t.co/xyzlrzMX8u

Day 1 of #CompCourse2025 is underway! 🚀   From expert sessions to hands-on training, it’s all about mastering structural complications in the cath lab. ✨ #CardioX #CardioTwitter #CardioEd #CardioResearch @KateKearney4 @DrBillLombardi @jamiemccabeMD @djc795 @jgranadacrf

💡Ready to put your research in the spotlight? Take the stage at #TCT2025 and show the world what you've been working on! Submit your abstract for a chance to: ✅ Join the elite TCT faculty ✅ Present your findings to a global audience ✅ Get published in the JACC abstract

🫀 New findings on the MATRIX technique presented by @ChantalAsselin at #NYValves2025! Early outcomes of this novel approach for high-risk mitral valve patients are now available in @crfshj. https://t.co/Geg1HQsB1c #CardioResearch

Our sincerest gratitude goes out to Anthony N. DeMaria, MD, who is retiring after his visionary leadership as the founding Editor-in-Chief of Structural Heart: The Journal of the Heart Team. His guidance has shaped the journal into a trusted resource for the structural heart

Welcome to MATRIX - shockwave lithotripsy of severe calcified MS in pts with no other options using oversized IVL balloons via a transseptal sheath to maximize annular contact. Congrats to our superstar resident Dr Asselin for a great presentation. Sim pub in @crfshj @crfheart

📢 New study presented at #NYValves2025 and published in Structural Heart (@crfshj) highlights key trends in aortic valve replacement for patients under 65 with severe aortic stenosis. @DrTGupta https://t.co/KnPnK3BbVd #CardioResearch

Innovation took center stage at #NYValves2025! 💡🫀 This late-breaking session, held in partnership with Structural Heart, delivered bold insights into the future of care. Moderated by Dr. Juan Granada and our new Editor-in-Chief, Dr. Josep Rodés-Cabau.

Catch the latest breakthroughs in structural heart care at #NYValves2025! 🚀 From novel implantable sensors to cutting-edge valve technologies, discover innovations shaping the future of treatments. 💡🫀 @crfshj @jgranadacrf @PradeepYadavMD @HamidNadira @drptca @BurkhoffMD

@IsabelMattig @eromerodorta @HenrykDreger @PopmaJeffrey

TAVR outcomes: Whether your annulus is a studio or a mansion, BEVs deliver. Flow-gradient drama? Doesn’t matter. Mortality & HF readmissions—same same. Size ≠ destiny. Check our 📜from @ClevelandClinic @CleClinicHVTI under @tavrkapadia by @BBachir97 👉 https://t.co/JmoxCnbt7F

New insights from a small study using AI-powered CT analysis for tricuspid valve interventions found: ✅ Deep learning enables fast, accurate right heart assessment ✅Results are consistent regardless of user experience https://t.co/XtLX0Iqnkn #CardioEd #CardioResearch

@FrazzettoMarco @ACUkaigweMD @GregRushingMD @GuiAttizzaniMD @PopmaJeffrey

🆕 Findings from CANNULATE TAVR II: Faster right coronary cannulation with the Evolut FX+ vs. previous-gen Despite ~50% of coronaries not aligning with valve apertures, 100% success rate using standard technique https://t.co/XBjOKsuB6F #CardioEd #CardioResearch

🚨 Final Hours to Save! Rates for #NYValves2025 increase on June 11, 2025, at 12:00 AM EDT (UTC -4). Register now!

@j_at_judah @IMotairek @SergeHarbMD @GrantReedMD @JamesJYunMDPhD @tavrkapadia @PopmaJeffrey